EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for SKYA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -0.3229
March 31, 2026 -1.188
December 31, 2025 -6.262
September 30, 2025 -4.327
June 30, 2025 0.0119
March 31, 2025 38.62
December 31, 2024 -662.99
September 30, 2024 -1.265
June 30, 2024 -2.145
March 31, 2024 -1.158
December 31, 2023 -4.467
September 30, 2023 -3.767
June 30, 2023 -4.918
Date Value
March 31, 2023 -4.329
December 31, 2022 -1.987
September 30, 2022 -5.730
June 30, 2022 1.142
March 31, 2022 -4.484
December 31, 2021 -3.832
September 30, 2021 -3.217
June 30, 2021 -1.944
March 31, 2021 -2.194
December 31, 2020 -2.040
September 30, 2020 -1.502
June 30, 2020 -1.139
March 31, 2020 -0.9315

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Daxor Corp. --
Strive, Inc. (United States) -3.770
Solana Co. -0.3794
Abbott Laboratories 0.5324
Acme United Corp. 1.220